Literature DB >> 6336623

Delineation of optimal conditions for producing mouse-human heterohybridomas from human peripheral blood B cells of immunized subjects.

J L Butler, H C Lane, A S Fauci.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336623

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  10 in total

1.  Development of human monoclonal antibodies: A review.

Authors:  T Lindl
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.

Authors:  N N Teng; K S Lam; F Calvo Riera; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

3.  Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization.

Authors:  L Winger; C Winger; P Shastry; A Russell; M Longenecker
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

4.  Characterization of human hybridomas secreting antibody to tetanus toxoid.

Authors:  J W Larrick; K E Truitt; A A Raubitschek; G Senyk; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

Review 5.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

6.  A human-mouse hybridoma producing monoclonal antibody against human sperm coating antigen.

Authors:  S D Kyurkchiev; M Shigeta; K Koyama; S Isojima
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

Review 7.  Human monoclonal antibodies: methods of production and some aspects of their application in oncology.

Authors:  L Olsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

8.  A human-human hybridoma secreting anti-Pseudomonas aeruginosa exotoxin-A monoclonal antibody with highly potent neutralizing activity.

Authors:  M Kuriyama; Y Ichimori; S Iwasa; K Tsukamoto
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.040

9.  Immortalization of human lymphocytes by fusion with cytoplasts of transformed mouse L cells.

Authors:  H Abken; H Jungfer; W H Albert; K Willecke
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

Review 10.  Exploring the native human antibody repertoire to create antiviral therapeutics.

Authors:  S K Dessain; S P Adekar; J D Berry
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.